Abstract:Objective To achieve the fully automated synthesis of myocardial fatty acid metabolism imaging agent 14(R, S)-[18F]fluoro-6-thia-heptadecanoic acid (18F-FTHA), its biological distribution characteristics in normal Kunming mice were evaluated. Methods An automated synthesis module benzyl-14-tosyloxy-6-thia-heptadecanoate was used as precursor. The synthesis process was completed in four steps: nucleophilic substitution, alkaline hydrolysis, semi-preparative high-performance liquid chromatography, and solid-phase extraction. The physical(traits, activity, specific activity, half-life, and radionuclide purity), chemical (chemical purity, radiochemical purity, and room temperature stability), and biological properties (toxicity, sterility, and bacterial endotoxin) of the compound were identified. Twenty Kunming mice were randomly divided into four groups, with five mice in each group. The imaging agent 18F-FTHA 7.4 MBq(volume<0.2 mL) was injected through the tail vein. A group of mice was sacrificed at 15, 30, 60, and 90 min after injection, and the blood and main organs, such as heart, liver, spleen, lung, kidney, muscle, and bone, were obtained and weighed. The radioactivity count was measured by a gamma counter. The radioactive uptake(% ID/g) was calculated. Results The total synthesis time was about 50 min. The synthetic yield was(10.0±1.7)%. The 18F-FTHA is an injection containing 10% ethanol. The compound is a sterile, endotoxin-free, colorless clear solution. Its pH value is 6-7, specific activity is 65 GBq/mmol, radioactive nuclear purity is ≥99%, and radiochemical purity is >98%, which remained at >95% after 6 h at room temperature. Biodistribution experiments in normal Kunming mice showed that 18F-FTHA rapidly cleared in the blood, and a high myocardial uptake and low non-target organ uptake were observed. At 60 min after injection, the radioactivity uptake of myocardium, lungs, and liver reached(19.04 ± 4.87)%ID/g, (3.05 ± 0.52)%ID/g and(5.99 ± 2.96)%ID/g, respectively. The heart-to-lung and heart-to-liver uptake ratios totaled 6/1 and 3/1, respectively. The liver uptake at 15 and 30 min was slightly higher than the myocardial uptake. Conclusions The synthesis of 18F-FTHA, which features high radiochemical purity and good stability, has been automatically completed. Physical, chemical, and biological property identification results confirmed that the compound is safe and reliable. The biological distribution experiments on mice confirmed that myocardial uptake was higher than that of non-target organs. Thus, 18F-FTHA is suitable for experimental research. Key words: Cardiac metabolism; Fatty acid; Positron emission tomography; 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid; Biodistribution

Synthesis and Biodistribution of 99Mtc-Carbonyltechnetium-labeled Fatty Acids

Preliminary Studies of a Novel Cyclopentadienyl Tricarbonyl Technetium-99M Fatty Acid Derivative for Myocardical Imaging.

Synthesis and Biological Evaluation of Fatty Acid Derivatives for Myocardial Imaging Containing [ 99m Tc(CO) 3 ] +

Synthesis and Bio-Evaluation of Tc-99m-Labeled Fatty Acid Derivatives for Myocardial Metabolism Imaging

Synthesis and Biological Evaluation of Fatty Acids Containing 99Mtc-Oxo and 99Mtc-Nitrido for Myocardial Metabolism Imaging

Preparation And Biodistribution Of Novel Tc-99m(Co)(3)-Cnr Complexes For Myocardial Imaging

Synthesis and Biodistribution of Novel Dipicolylamine 99m Tc-(CO) 3 -Labeled Fatty Acid Derivatives for Myocardial Imaging

Preparation and Preliminary Evaluation of a Promising 99Mtc-Labeled Isonitrile-Containing 6-Thia-fatty Acid Derivative for Myocardial Metabolism Imaging

Initial Evaluation of 99m Tc-tricarbonyl-cyclopentadienyl Fatty Acids Derivatives As SPECT Tracers for Myocardium.

Synthesis and biological evaluation of fatty acids conjugates bearing cyclopentadienyl-donors incorporated [99mTc/Re(CO)3] + for myocardical imaging

Synthesis, separation and biodistribution of99mTc-CO-MIBI complex

Synthesis And Biodistribution Of A Novel [(Tcn)-Tc-99m(Pnp5)(Dmchdtc)](+) Complex As A Potential Myocardial Perfusion Imaging Agent

Synthesis, Characterization and Biodistribution of New Fatty Acids Conjugates Bearing N,N,N-donors Incorporated [99Mtc/re(co)3]+.

Synthesis of Labelled Small Peptide Complexes for Imaging Agents with Technetium-99M and Biodistribution in Mice.

Synthesis and biodistribution of a novel 99m Tc nitrido dithiocarbamate complex containing ether group as a potential myocardial and brain imaging agent

Synthesis and biodistribution of a novel [99mTcN(PNP5)(DMCHDTC)]+ complex as a potential myocardial perfusion imaging agent.

Synthesis of a Bis(2,3-Dimethylcyclohexyl-dithiocarbamato)-nitrido 99mtc Complex: A Potential Tracer for Myocardial Imaging

Synthesis of New N2S Ligands, Preparation of 99mtc Complexes and Their Preliminary Biodistribution in Mice

Preparation and Biological Evaluation of 99Mtc-Co-mibi As Myocardial Perfusion Imaging Agent

Automated Synthesis and Biodistribution Study of Cardiac Fatty Acid Metabolism Imaging Agent 18F-FTHA

New Bato Complexes for Brain and Myocardial Imaging